RAGE in tissue homeostasis, repair and regeneration

Biochim Biophys Acta. 2013 Jan;1833(1):101-9. doi: 10.1016/j.bbamcr.2012.10.021. Epub 2012 Oct 26.

Abstract

RAGE (receptor for advanced glycation end-products) is a multiligand receptor of the immunoglobulin superfamily involved in inflammation, diabetes, atherosclerosis, nephropathy, neurodegeneration, and cancer. Advanced glycation end-products, high mobility group box-1 (amphoterin), β-amyloid fibrils, certain S100 proteins, and DNA and RNA are RAGE ligands. Upon RAGE ligation, adaptor proteins (i.e., diaphanous-1, TIRAP, MyD88 and/or other as yet unidentified adaptors) associate with RAGE cytoplasmic domain resulting in signaling. However, RAGE activation may not be restricted to pathological statuses, the receptor being involved in tissue homeostasis and regeneration/repair upon acute injury, and in resolution of inflammation. RAGE effects are strongly dependent on the cell type and the context, which may condition therapeutic strategies aimed at reducing RAGE signaling.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Glycation End Products, Advanced / metabolism
  • Glycation End Products, Advanced / pharmacology
  • Glycation End Products, Advanced / physiology
  • Homeostasis / drug effects
  • Homeostasis / genetics*
  • Homeostasis / physiology
  • Humans
  • Models, Biological
  • Receptor for Advanced Glycation End Products
  • Receptors, Immunologic / genetics
  • Receptors, Immunologic / metabolism
  • Receptors, Immunologic / physiology*
  • Regeneration / drug effects
  • Regeneration / genetics*
  • Regeneration / physiology
  • Signal Transduction / drug effects
  • Signal Transduction / genetics
  • Signal Transduction / physiology
  • Wound Healing / drug effects
  • Wound Healing / genetics*
  • Wound Healing / physiology

Substances

  • Glycation End Products, Advanced
  • Receptor for Advanced Glycation End Products
  • Receptors, Immunologic